Evaluation of a Patient Portal Intervention to Address Diabetes Care Gaps

Vanderbilt University Medical Center

Status: Completed

Conditions: Diabetes Mellitus

Treatments: Other: Diabetes Care Gaps Patient Portal Intervention

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT04728620

R18DK123373-01 (U.S. NIH Grant/Contract)

202281

Details and patient eligibility

About

The purpose of this study is to evaluate the usability of a novel patient portal intervention designed to: (a) notify patients when selected, clinically meaningful, evidence-based diabetes monitoring & preventative care (e.g., annual diabetes eye exam) become due and (b) allow patients to initiate orders for the care. In addition, the investigators will assess pre-post change on secondary psychosocial outcomes (e.g., self-efficacy).

Full description

Up to 60 adult patients with type 1 or 2 diabetes mellitus will be enrolled and given access to a new feature within the patient portal at Vanderbilt University Medical Center. The new feature will be available via the patient portal native app (i.e., My Health at Vanderbilt (MHAV) app) for mobile devices (smartphone or tablet). The new feature will allow patients to: (1) receive notifications when the patient is due for certain types of diabetes monitoring and preventative care and (2) initiate an order for the care.

Study participants will complete questionnaires electronically via email at three time points: baseline (T0), immediately after first use of the intervention (T1), and three-month follow-up (T2) to as assess study outcomes including usability and pre-post change in secondary psychosocial outcomes.

Enrollment: 60 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Established patient at participating primary care clinic
• Type 1 or 2 diabetes mellitus
• Able to speak and read in English
• Age 18 to 75 years old
• Mobile device (smartphone or tablet) with internet access
• Active MHAV account and willing and able to use the MHAV native app on a mobile device
• Due (based on evidence-based guidelines) for any of the following: hemoglobin A1C, urine microalbumin, diabetes eye exam, and/or pneumococcal vaccination.

Exclusion criteria

• Known cognitive deficits or functional impairment preventing the use of a mobile device
• Pregnant or planning to become pregnant during the study period
• Severe difficulty seeing
• Severe difficulty hearing
• Medical condition that make it hard for people to understand what they are saying

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

60 participants in 1 patient group

Intervention

Experimental group

Description:

Participants will have access to a new feature within an established patient portal native app on mobile devices. The new feature aims to address diabetes care gaps.

Treatment:

Other: Diabetes Care Gaps Patient Portal Intervention